PNGM.US Er Therapeutics Inc
- Market cap
- USD 5.83K
- P/E
- -
- P/B
- 143,650.38x
- ROE
- -
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Aug 2011.
Is PNGM.US undervalued?
Graham numberThe Graham number of Er Therapeutics Inc cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Er Therapeutics Inc fundamental analysis
No fundamental analysis for Er Therapeutics Inc yet.
Er Therapeutics Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Er Therapeutics Inc
Pengram Corporation operates as a gold exploration company. The company was incorporated in 2006 and is based in Bellingham, Washington.
Full company profileEr Therapeutics Inc financial statements
2011 annualized: Fiscal year 2011 is not finished. Income statement and cash flow are annualized from 3 quarters up to Aug 31, 2011, the balance sheet is the latest quarter. Figures change when the annual report is published.
Er Therapeutics Inc annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2007 | 2008 | 2009 | 2010 | 2011 Anlz |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Income | -103K | -134K | -290K | -311K | -789K |
| Net Income | -108K | -139K | -376K | -427K | -664K |
| Balance Sheet | |||||
| Total Assets | 11.4K | 141K | 454K | 424K | 389K |
| Total Liabilities | 10.9K | 200K | 375K | 536K | 645K |
| Shareholders' Equity | 485.00 | -58.6K | 79.4K | -112K | -255K |
| Cash & Short-term Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Flow | |||||
| Operating Cash Flow | -91.0K | -42.0K | -204K | -161K | -203K |
| Capital Expenditure | 1.52K | 10.0K | 10.0K | 68.1K | 0.00 |
| Ratios | |||||
| ROE | -22,347.2% | - | -473.2% | - | - |
| ROA | -950.4% | -98.6% | -82.6% | -100.8% | -170.6% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
Er Therapeutics Inc dividends
Er Therapeutics Inc has not paid dividends in the last 4 fiscal years.
Last stock split: 3:1 on Apr 13, 2009.
Who owns Er Therapeutics Inc
Ownership data of Er Therapeutics Inc is not available yet.
Er Therapeutics Inc company profile
- Company name
- Er Therapeutics Inc
- Ticker
- PNGM.US
- Exchange
- USA Stocks
- Sector
- Basic Materials
- Industry
- Metals & Mining
- Fiscal year end
- November
- Address
- 1200 Dupont Street, Bellingham, WA, United States, 98225
- Phone
- 360-255-3436
- Website
- pengramgold.com
About Er Therapeutics Inc
Pengram Corporation operates as a gold exploration company. The company was incorporated in 2006 and is based in Bellingham, Washington.
Er Therapeutics Inc management
1- Mr. Richard W. DonaldsonCEO, President, CFO, Principal Accounting Officer, Secretary, Treasurer and Director · born 1939